- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2022 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
All News
How Evolving Safety Has Changed the Outlook on Bariatric, Metabolic Surgery, with Gregory Weiss, MD
December 02, 2022
Gregory Weiss, MD, provides perspective on how improved safety of these procedures has revolutionized the way clinicians view use of bariatric and metabolic surgeries as a method for inducing weight loss in people with overweight and obesity.
Female Sex, Increased BMI Linked to Increased Likelihood of Long COVID
December 01, 2022
An analysis of survey data from more than 1400 adults in the UK provides insight into potential risk factors for developing long COVID symptoms, with results indicating both female sex and increased body mass index as potential risk factors.
"Green" Mediterranean Diet Could Reduce Visceral Adiposity by 14%
November 30, 2022
Results of the DIRECT-PLUS trial provide clinicians with new insights into the impact of the Mediterranean diet and a modified Mediterranean diet as a method for inducing weight loss.
Blood Glucose at Admission Could Serve as Prognostic Marker in Emergency Departments
November 29, 2022
An analysis of data from patients admitted to emergency departments from 7 hospitals in Sweden provide insight into the potential of blood glucose at admission for use as a biomarker to predict all-cause mortality and cardiovascular risk in patients without a history of diabetes.
Co-Occuring Gestational Diabetes, Hypertension Linked with Doubling of Future Cardiovascular Risk
November 28, 2022
An analysis of more than 800k women in Canada provides insight into the apparent increase in risk of incident cardiovascular disease associated with co-occurrence of gestational diabetes and gestational hypertensive disorders in pregnant women.
Endocrine Month in Review: November 2022
November 26, 2022
The November 2022 endocrine month in review features coverage of the FDA’s approval of teplizumab, new data related to use of GLP-1 receptor agonists, and a trio of stories on topics pertaining to diabetes technology.
Incorporating Weight Training Into Physical Activity Regimen Linked to Reduced Mortality in Type 2 Diabetes
November 25, 2022
An analysis of data from the Health Professionals Follow-Up Study suggests incorporating weight training into physical activity regimens was associated with reduced mortality in patients with or without type 2 diabetes, with the association in those without diabetes present even after adjustment for aerobic activity levels.
Black Patients Less Likely to be Prescribed, Have Discussions around CGMs, Insulin Pumps
November 24, 2022
A Johns Hopkins-led analysis provides a snapshot of trends in racial disparities seen in both uptake of and engagement in discussions with providers around continuous glucose monitoring and insulin pumps among adults with type 1 diabetes.
Universal Screening for Adults 40-70 Years Old Could Identify Most Diabetes Cases 2 Years Earlier
November 23, 2022
Using data from the UK Biobank study, a team of investigators from the University of Exeter determined undiagnosed cases of type 2 diabetes could be identified more than 2 years earlier if universal screening programs were implemented for middle-aged adults.
European Study Links Antibiotic Exposure to Increased Risk of Type 2 Diabetes Later in Life
November 22, 2022
An analysis of data from a pair of studies examining cardiovascular risk in individuals from countries in Europe provides insight into an apparent increase in the likelihood of developing type 2 diabetes among people with a history of exposure to antibiotics.